KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Other Working Capital Changes (2016 - 2025)

Rigel Pharmaceuticals has reported Other Working Capital Changes over the past 16 years, most recently at $3.4 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $3.4 million for Q4 2025, up 7797.73% from a year ago — trailing twelve months through Dec 2025 was $11.8 million (up 244.42% YoY), and the annual figure for FY2025 was $11.8 million, up 244.42%.
  • Other Working Capital Changes for Q4 2025 was $3.4 million at Rigel Pharmaceuticals, up from $1.9 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for RIGL hit a ceiling of $7.7 million in Q4 2021 and a floor of -$10.9 million in Q3 2021.
  • Median Other Working Capital Changes over the past 5 years was $495500.0 (2024), compared with a mean of $259600.0.
  • Biggest five-year swings in Other Working Capital Changes: tumbled 443.78% in 2021 and later surged 7797.73% in 2025.
  • Rigel Pharmaceuticals' Other Working Capital Changes stood at $7.7 million in 2021, then plummeted by 194.8% to -$7.3 million in 2022, then soared by 84.72% to -$1.1 million in 2023, then surged by 96.05% to -$44000.0 in 2024, then surged by 7797.73% to $3.4 million in 2025.
  • The last three reported values for Other Working Capital Changes were $3.4 million (Q4 2025), $1.9 million (Q3 2025), and $5.6 million (Q2 2025) per Business Quant data.